Status: Recruiting
Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients
the standard induction treatment for pediatric acute myeloid leukemia has high early morbidity and mortality that jeopardize the outcome especially in developing countries. SIOP recommended lower dose induction synergistic G- CSF to minimize these unwanted toxicities. the study aimed at minimizing the toxicities during induction without jeopardizing the survival.
Participants needed: 33
Trial details
Age: Up to 18Biological sex: AllType: InterventionalSponsor: Azza Shibl SayedUpdated: Oct 9, 2026Locations: 2
Eligibility criteria
Denovo pediatric AML patients. [+1]
Children with promyelocytic leukemia [+3]